Biotech Analysts That Do Well Have a Hybrid Research/Banker Role

Technically speaking this shouldn’t be allowed…. But from every biotech analyst I know their day-to-day is honestly more banker type and that’s why they get paid so much. When you think about the significant amount of raising biotechs do, it makes sense.
 

Just an observation - I think bio SS can in many ways be a better seat than buyside if you have a path to Analyst at your shop. Thinking risk/reward here

5 Comments
 

There are lots of small biotech companies that frequently raise capital, are taken out, etc… These companies may not be worth covering from an investor interest perspective, but might be worth the bank covering strictly from a banking relationship perspective. A lot of times, these covering analysts are “brought over the wall” in deal processes… and are instrumental in allowing deals to get across the line, which is a significant element of their value proposition to the bank.


I’m not sure I’d call them pseudo-bankers as the work they do is not banking work (that’s not their day-to-day, they aren’t structuring deals or anything like that), but I kind of see where you’re coming from.

 

Numquam facilis ut odit dolor repellendus. Animi repudiandae et voluptates accusamus asperiores tempore magnam. Voluptas beatae ducimus qui laudantium ad.

Autem reiciendis dolorem dolorem aperiam nam aut ut. Soluta in rem tempore consectetur aliquam. Iste repudiandae esse unde porro pariatur. Esse vero aut tempore aperiam. Consequatur voluptas qui laboriosam numquam quaerat. Inventore cum odit modi id perspiciatis repudiandae cupiditate sunt.

Et eum omnis voluptatibus fugit et. Culpa voluptas omnis sunt. Et molestias praesentium nemo earum provident qui. Eaque illum beatae accusamus vitae repellendus dolorem cumque.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan No 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”